Literature DB >> 15991869

Myotonic dystrophy: muscle involvement in relation to disease type and size of expanded CTG-repeat sequence.

Anna-Karin Kroksmark1, Anne-Berit Ekström, Eva Björck, Már Tulinius.   

Abstract

This study aimed to: classify a cohort of children and adolescents with myotonic dystrophy (dystrophia myotonica: DM) into congenital and childhood onset forms; estimate CTG expansion size; and quantify muscle strength, contractures, and motor function in children with DM and compare results with those of controls. Participants were clinically examined, medical records were reviewed, and isometric muscle strength, contractures, and motor function were measured. Participants were: 42 children with DM (18 females, 24 males; mean age 8y 9mo [SD 4y 7mo], range 10mo to 17y) and 42 age- and sex-matched, healthy controls. Children with DM were divided into three groups: severe congenital (n=13), mild congenital (n=15), and childhood (n=14). Children with childhood DM were significantly weaker than controls (wrist and ankle dorsiflexors [p=0.0044, p=0.0044 respectively]; hip abductors and flexors [p=0.0464, p=0.0217]; and knee flexors and extensors: [p=0.0382, p=0.0033]). Children with mild congenital DM were significantly weaker than controls in all assessed muscle groups. Contractures and skeletal deformities were more frequent at time of investigation than at birth, suggesting that foot and spine deformities in particular increase over time. Motor function score was significantly lower for children with DM than for controls. Children with severe congenital DM had the lowest motor function, with correlation between motor function and size of CTG repeat (p=-0.743). Children found jumping, heel standing, and head lifting the most difficult items to perform but few had difficulty walking, running, or stair climbing. DM in children is a heterogeneous disorder with a wide spectrum of muscle involvement, and owing to increased risk of contractures and skeletal deformities, regular follow-ups are recommended.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991869     DOI: 10.1017/s0012162205000927

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  11 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  Physical function and mobility in children with congenital myotonic dystrophy.

Authors:  Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

3.  12-Month progression of motor and functional outcomes in congenital myotonic dystrophy.

Authors:  Kellen H Quigg; Kiera N Berggren; Melissa McIntyre; Kameron Bates; Francesca Salmin; Jacopo L Casiraghi; Adele DʼAmico; Guja Astrea; Federica Ricci; Marnee J McKay; Jennifer N Baldwin; Joshua Burns; Craig Campbell; Valeria A Sansone; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2021-01-10       Impact factor: 3.217

4.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

5.  The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.

Authors:  Luc J Hébert; Jean-François Remec; Joanne Saulnier; Christophe Vial; Jack Puymirat
Journal:  BMC Musculoskelet Disord       Date:  2010-04-18       Impact factor: 2.362

Review 6.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

7.  Cortical Thickness and White Matter Integrity are Associated with CTG Expansion Size in Myotonic Dystrophy Type I.

Authors:  Woo Kyoung Yoo; Yoon Ghil Park; Young Chul Choi; Sun Mi Kim
Journal:  Yonsei Med J       Date:  2017-07       Impact factor: 2.759

8.  Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy.

Authors:  Yu Saito; Kenta Matsumura; Misao Kageyama; Yuichi Kato; Eiji Ohta; Kiyoaki Sumi; Takeshi Futatani; Taketoshi Yoshida
Journal:  BMC Res Notes       Date:  2020-07-23

9.  AMC: amyoplasia and distal arthrogryposis.

Authors:  Eva Kimber
Journal:  J Child Orthop       Date:  2015-11-04       Impact factor: 1.548

10.  Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.

Authors:  Lucie Picchio; Vincent Legagneux; Stephane Deschamps; Yoan Renaud; Sabine Chauveau; Luc Paillard; Krzysztof Jagla
Journal:  Dis Model Mech       Date:  2018-05-21       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.